Inhaled IL-15 offers the advantages of regional delivery to the lungs, which is the site of metastatic dissemination in the vast majority of OSA patients after surgery and chemotherapy for localized disease. This evidence concerns the gene IL15 and obstructive sleep apnea syndrome.